GE HealthCare Inc. (GEHC) - Rasio tanggungan utang jangka dawa marang modal

GE HealthCare - logo grafis emiten GEHC

GE HealthCare (GEHC) ensures a stable cash flow through a combination of equipment sales and subsequent support, creating a predictable revenue base. This chart reflects the asset value on the GURU.Markets platform at 0.90, allowing for an assessment of the impact of government spending and AI technologies on revenue and EBIT margins. Global dominance in complex imaging and proprietary software create powerful defensive barriers.

GE HealthCare Technologies (GEHC): Utang jangka dawa marang modal saka 28.04.2023 nganti 30.10.2026
Sampel barang GE Healthcare Corp

This metric determines the financial stability of GE HealthCare (GEHC) by measuring the proportion of liabilities with a maturity exceeding one year relative to total capital, including market capitalization. By analyzing the long-term debt-to-equity trend on GURU.Markets, an investor can assess the issuer's ability to service loans amid potential government budget cuts for the procurement of expensive medical equipment in the US and Europe.

Perusahaan pesaing

Rasio utang jangka dawa marang modal ABT (Abbott Labs)|Utang jangka dawa marang modal TMO|Rasio tanggungan utang jangka dawa marang modal Mettler Toledo Inc|Utang jangka dawa marang modal WAT (Waters Corporation)|Utang jangka dawa marang modal bio-techne.com TECH|Bruker - Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas Azenta Inc (AZTA)|Varex (VREX) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal SMLR|Utang jangka dawa marang ekuitas Butterfly Network, Inc.|Kewajiban jangka dawa marang modal mesalabs.com MLAB|Utang jangka dawa marang ekuitas Quantum-Si Incorporated (QSI)|Rasio tanggungan utang jangka dawa marang modal Nano-X Imaging|Quanterix Corp - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal MASS (908 Devices Corporation)|CapsoVision Medical - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal maxcyte.com MXCT|RPID: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Seer Inc|Rasio utang jangka dawa marang ekuitas HYPR|FONR: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Daxor Corporation (DXR)|Rasio utang jangka dawa marang ekuitas Spectral AI Inc. MDAI|Utang jangka dawa marang modal VIVS (Organovo Holdings, Inc.)|Aclarion Inc (ACON) - Kewajiban jangka dawa marang modal|Akoya - Utang jangka dawa marang modal|THMO (Cesca Therapeutics) - Rasio utang jangka dawa marang modal|TLIS: Utang jangka dawa marang modal|TTOO - Rasio tanggungan utang jangka dawa marang modal